Found 0 matching trials
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC(neoSCORE Ⅱ) PHASE3 This is a Phase 3, prospective, randomized, open-label, multi-center study ...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy NA This diagnostic study investigates the value of 68Ga-NOTA-GZP PET imaging i...
Show More Location
Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
Learn More & Join Trial
Neoadjuvant Immunochemotherapy for LAOSCC PHASE3 To evaluate the prognostic efficacy of neoadjuvant immunochemotherapy with ...
Show More Location
Huashan Hospital, Fudan University
Learn More & Join Trial
Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma (neoHNSCC) N/A This is a retrospective, single-arm study that assesses the efficacy and sa...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer PHASE2 Neoadjuvant accelerated methotrexate/vinblastine/adriamycin/cisplatin (AMVA...
Show More Status
Active Not Recruiting
Location
UNC Lineberger Comprehensive Cancer Center
Learn More & Join Trial
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer PHASE2 Esophageal cancer is one of the most common malignancies, and concurrent ch...
Show More Location
The First Affiliated Hospital of Nanjing Medical University
Learn More & Join Trial
Camrelizumab Plus R-CHOP Regimen in Untreated Primary Extranodal DLBCL PHASE2 To assess the efficacy and safety of camrelizumab combined with rituximab, ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC PHASE2 This is a Phase II, prospective, randomized, open label, controlled, multi-...
Show More Location
Tangdu Hospital of the Fourth Millitary Medical University
Learn More & Join Trial
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. PHASE2 This is a prospective, phase 2, multicenter, open-label, single-arm study. ...
Show More Status
Active Not Recruiting
Location
ASST Spedali Civili di Brescia
Learn More & Join Trial
Minimally Residual of Esophageal Cancer 001 N/A This trial aims to assess changes in minimal residual disease (MRD) status ...
Show More Location
Fourth Hospital of Hebei Medical University
Learn More & Join Trial